Pfizer 2Q11 2Q Revenues: $17.0 billion (-1%) 2Q Earnings: $2.6 billion (+5%) YTD Revenues: $33.5 billion (-1%) YTD Earnings: $4.8 billion (+7%) Comments: Currency exchange rates (+4%) and revenues from the King Pharmaceuticals acquisition (+2%) kept revenues from a significant drop. Primary Care revenues for 2Q11 were $5.9 billion (-1%), Specialty Care revenues were $3.7 billion (-2%), sales in Emerging Markets grew 7% to $2.4 billion, Established Products sales dropped 15% to $2.3 billion,...